Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): A randomised, double-blind, parallel-group trial

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): A randomised, double-blind, parallel-group trial

Näytä muut versiot (1)

Background: Patients with ischaemic stroke or transient ischaemic attack (TIA) are at high risk of recurrent stroke or other cardiovascular events. We compared the selective thromboxane-prostaglandin receptor antagonist terutroban with aspirin in the prevention of cerebral and cardiovascular ischaem...

Bibliografiset tiedot
Päätekijät:	Bousser, M, Amarenco, P, Chamorro, A, Fisher, M, Ford, I, Fox, K, Hennerici, MG, Mattle, H, Rothwell, P, De Cordoüe, A, Fratacci, M
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2011

Samankaltaisia teoksia

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial.
Tekijä: Bousser, MG, et al.
Julkaistu: (2011)

Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.
Tekijä: Bousser, MG, et al.
Julkaistu: (2009)

The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the population.
Tekijä: Bousser, MG, et al.
Julkaistu: (2009)

Heart rate is a prognostic risk factor for myocardial infarction: a post hoc analysis in the PERFORM (Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack) study population.
Tekijä: Fox, K, et al.
Julkaistu: (2013)

Heart rate is a prognostic risk factor for myocardial infarction: A post hoc analysis in the PERFORM (Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history of ischemic strOke or tRansient ischeMic attack) study population
Tekijä: Fox, K, et al.
Julkaistu: (2013)

Rationale, design and patients' baseline characteristics of the PERFORM study
Tekijä: Bousser, MG, et al.
Julkaistu: (2009)

The Intracranial-B2LEED3S score and the risk of intracranial hemorrhage in ischemic stroke patients under antiplatelet treatment.
Tekijä: Amarenco, P, et al.
Julkaistu: (2017)

Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke.
Tekijä: Rothwell, P, et al.
Julkaistu: (2011)

Medical treatment in acute and long-term secondary prevention after transient ischaemic attach and ischaemic stroke
Tekijä: Rothwell, P, et al.
Julkaistu: (2011)

Specificities of ischemic stroke risk factors in Arab-speaking countries
Tekijä: Abboud, H, et al.
Julkaistu: (2017)

Cost-effectiveness of ticagrelor plus aspirin versus aspirin in acute ischaemic stroke or transient ischaemic attack: an economic evaluation of the THALES trial
Tekijä: Yongjun Wang, et al.
Julkaistu: (2023-10-01)

Aspirin and transient ischaemic attacks.
Tekijä: Peto, R, et al.
Julkaistu: (1979)

Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials
Tekijä: Rothwell, PM, et al.
Julkaistu: (2016)

Immediate aspirin for suspected ischaemic stroke.
Tekijä: Baigent, C, et al.
Julkaistu: (1999)

Preliminary evidence of a high risk of bleeding on aspirin plus clopidogrel in aspirin-naive patients in the acute phase after TIA or minor ischaemic stroke.
Tekijä: Geraghty, O, et al.
Julkaistu: (2010)

Atherothrombosis and ischaemic stroke.
Tekijä: Rothwell, P
Julkaistu: (2007)

Atherothrombosis and ischaemic stroke
Tekijä: Rothwell, P
Julkaistu: (2007)

Effects on colon cancer risk in randomised trials of aspirin
Tekijä: Rothwell, P
Julkaistu: (2011)

Apolipoproteins predict ischaemic stroke in patients with a previous transient ischaemic attack
Tekijä: Bhatia, M, et al.
Julkaistu: (2004)

Recent advances in management of transient ischaemic attacks and minor ischaemic strokes.
Tekijä: Rothwell, P, et al.
Julkaistu: (2006)

Aspirin in the prevention of cancer Reply
Tekijä: Rothwell, P
Julkaistu: (2011)

Low birthweight and ischaemic heart disease.
Tekijä: Rothwell, P
Julkaistu: (1994)

Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial
Tekijä: Yongjun Wang, et al.

Comparison of Different Laboratory Tests to Identify “Aspirin Resistance” and Risk of Vascular Events among Ischaemic Stroke Patients: A Double-Blind Study
Tekijä: Narayanaswamy Venketasubramanian, et al.
Julkaistu: (2022-05-01)

Apolipoproteins as predictors of ischaemic stroke in patients with a previous transient ischaemic attack.
Tekijä: Bhatia, M, et al.
Julkaistu: (2006)

Prevalence of Aspirin and Clopidogrel Resistance in Patients with Recurrent Ischaemic Cerebrovascular Disease
Tekijä: Niyata Hananta Karunawan, et al.
Julkaistu: (2021-12-01)

Comparison of effectiveness of aspirin, clopidogrel and cilostazol monotherapy treatment in ischaemic stroke
Tekijä: Endarwati Tuti, et al.
Julkaistu: (2025-01-01)

Familiar frequency of ischaemic stroke and transient ischaemic attack in relation to clinical subtype and intermediate phenotypes
Tekijä: Rothwell, P, et al.
Julkaistu: (2001)

Transient ischaemic attacks: time to wake up.
Tekijä: Rothwell, P
Julkaistu: (2007)

Thromboxane–prostaglandin receptor antagonist, terutroban, prevents neurovascular events after subarachnoid haemorrhage: a nanoSPECT study in rats
Tekijä: David Lagier, et al.
Julkaistu: (2019-02-01)

Indications for early aspirin use in acute ischaemic stroke: A combined analysis of over 40,000 randomised patients
Tekijä: Chen, Z, et al.
Julkaistu: (1999)

Comparative evaluation of treatment with low-dose aspirin plus dipyridamole versus aspirin only in patients with acute ischaemic stroke
Tekijä: Arnarsdottir Lola, et al.
Julkaistu: (2012-08-01)

CAST: Randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke
Tekijä: Chen, Z, et al.
Julkaistu: (1997)

Paramedics should delay giving aspirin to patients with stroke.
Tekijä: Ward, M, et al.
Julkaistu: (2000)

Genetic epidemiology of ischaemic stroke
Tekijä: Flossmann, E, et al.
Julkaistu: (2004)

The need for emergency treatment of TIA and "minor" ischaemic stroke
Tekijä: Rothwell, P
Julkaistu: (2005)

Posterior circulation ischaemic stroke and transient ischaemic attack: diagnosis, investigation, and secondary prevention.
Tekijä: Markus, H, et al.
Julkaistu: (2013)

Asymptomatic recurrent cerebral ischaemic lesions on diffusion-weighted imaging in the subacute and chronic phase after transient ischaemic attack or minor ischaemic stroke.
Tekijä: Mazzucco, S, et al.
Julkaistu: (2007)

Mitochondrial DNA haplogroups and risk of transient ischaemic attack and ischaemic stroke: a genetic association study.
Tekijä: Chinnery, P, et al.
Julkaistu: (2010)

Alternate-day, low-dose aspirin and cancer risk.
Tekijä: Rothwell, P
Julkaistu: (2013)